$IPWR

Ideal Power Inc. (NASDAQ:IPWR) Short Interest Update

Ideal Power Inc. (NASDAQ:IPWR) saw short interest rise sharply in May, reaching 199,504 shares as of May 15, up 241.3% from 58,447 on April 30; short interest equals 1.6% of shares, with a days-to-cover ratio of 0.3. The article also notes a March 28 downgrade to “sell” and a $10.75 consensus price target.

Original reporting
Published May 31, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 31, 2026, 2:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ideal Power Inc. (NASDAQ:IPWR) Short Interest Update — source image
Decision brief

The 30-second read

$IPWRBearishMed
01

Why it matters

Rising short interest can pressure the stock if it coincides with weak demand expectations, while low days-to-cover reduces the probability of a near-term short squeeze.

02

Market read

Traders may reassess IPWR’s near-term risk profile given the sharp increase in short interest and the bearish rating reference.

03

What to watch

The article mixes short-interest data with an older analyst downgrade mention and May 14 earnings results; without follow-on guidance or contract news, the signal may be more positioning-driven than fundamental.

Relevance 8/10Novelty 8/10Timing: short-interest update as of May 15 (published May 31)

Background

Ideal Power (IPWR) designs power-conversion solutions; the article focuses on May short-interest and mentions a prior earnings release (May 14) and a March 28 rating cut.

Company-level read

Ticker impact

$IPWRBearishMedium confidence
Context

Article reports a 241% jump in Ideal Power’s short interest to 199,504 shares as of May 15, signaling rising bearish positioning.

Expected impact

Choppy-to-down bias possible as short positioning rises; low days-to-cover suggests less immediate squeeze risk.

Evidence & confidence

The piece provides a concrete short-interest datapoint (May 15 vs Apr 30) plus a downgrade mention, but lacks new fundamentals beyond the already-reported May 14 earnings miss.

Market effects

May short-interest spike can reflect broader risk-off sentiment toward small-cap industrial/power-conversion names, but no sector-wide catalyst is cited.

Primarily US small-cap sentiment; no specific regional linkage beyond NASDAQ listing.

No direct global linkage; power-conversion demand is mentioned only as business background.

Counterpoint

Low days-to-cover (0.3) implies shorts may not be crowded, so the short-interest jump may not translate into an immediate price collapse or squeeze.

Key entities

  • Ideal Power Inc.

    Subject of the short-interest update; short interest rose 241% in May and the stock recently traded around $7.44.

  • Jane Street Group LLC

    Purchased a new position in IPWR during Q2 (small dollar amount cited).

  • Vanguard Group Inc.

    Increased its stake by 4.9% during Q3, owning 359,089 shares per the article.

Related articles

$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.

$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

$RMDMed

Off Into Weekend, As Early Work Undone

ResMed (ASX:RMD) fell 8.29% on Friday and is 3.09% lower for the week after a strong run. The company reported a solid Q4, with FY26 revenue up 10% to $5.7b, gross Q4 margin 62.3%, FY EPS up 17% to $11.17, and a 10% dividend increase to $0.66. Morgan Stanley downgraded to Equal Weight and cut its price target, citing cooling growth and Philips’ potential US return in 2027.